Molecular cloning and characterization of gene encoding novel puromycin-inactivating enzyme from blasticidin S-producing Streptomyces morookaensis

Journal of Bioscience and Bioengineering
Motohiro NishimuraM Sugiyama

Abstract

Puromycin (PM) is classified into a family of nucleoside antibiotics together with blasticidin S (BS). PM-producing Streptomyces alboniger is known to express a PM-inactivating enzyme as a self-resistance determinant, which catalyzes the acetylation of PM. We have shown that, although BS-producing Streptomyces morookaensis also produces a PM-inactivating enzyme, it catalyzes the hydrolysis of an amide linkage between the aminonucleoside and O-methyl-L-tyrosine moiety of PM. In the present study, we cloned and characterized a gene encoding PM hydrolase (PMH) from BS-producing S. morookaensis JCM4673. The nucleotide sequence analysis suggests that an open reading frame consisting of 1986 bp is a gene for PMH and encodes a protein consisting of 662 amino acids with a calculated molecular mass of 71,260 Da. The molecular mass of the recombinant PMH, which was produced using an Escherichia coli host-vector system, was the same as that of PMH purified from the JCM4673 strain. Our biochemical study of the recombinant PMH confirmed that the enzyme is an aminopeptidase with broad substrate specificity. The putative primary structure of PMH contains a Gly-X-Ser-X-Gly motif, which is commonly observed among serine proteases. In addition, ...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Sep 15, 1989·Biochemical and Biophysical Research Communications·C NishimuraH Yamaguchi
Sep 1, 1985·Journal of General Microbiology·J S FeitelsonD A Hopwood
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J F Bazan, R J Fletterick
Jun 1, 1986·The Journal of Antibiotics·M SugiyamaR Nomi
May 1, 1985·Journal of Biochemistry·T Yoshimoto, D Tsuru
Aug 1, 1985·Journal of General Microbiology·M SugiyamaR Nomi
Feb 1, 1983·Journal of Biochemistry·T YoshimotoD Tsuru
Jun 29, 1983·Biochemical and Biophysical Research Communications·J A Pérez-GonzálezA Jiménez
Apr 18, 1998·Biochimica Et Biophysica Acta·M Y Mistou, J C Gripon
Jan 1, 1995·Biotechnology Annual Review·M A Goldstein, R H Doi
Apr 15, 1961·Proceedings of the National Academy of Sciences of the United States of America·D NATHANS, F LIPMANN

❮ Previous
Next ❯

Citations

Sep 29, 2011·Applied and Environmental Microbiology·Jiro ArimaNobuhiro Mori
May 26, 2010·Applied Microbiology and Biotechnology·Jiro ArimaTadanori Aimi
Jul 4, 2012·Applied and Environmental Microbiology·Weixin TaoSeon-Woo Lee
Sep 26, 2019·Current Protein & Peptide Science·Anna J Kiss-SzemánDóra K Menyhárd

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.